Cannabix Technologies’ Marijuana Breath Test to Make Debut at NDASA Conference
VANCOUVER, British Columbia – In an exciting development for the cannabis industry and the field of drug testing, Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) is preparing to showcase its Marijuana Breath Test (MBT) at the National Drug and Alcohol Screening Association (NDASA) conference in Florida. The event, which attracts corporations and professionals in the drug and alcohol testing industry from around the world, will mark the beginning of joint marketing efforts between Cannabix and strategic partner, Omega Laboratories.
Laboratory Validation Milestone
The announcement follows a significant achievement for Cannabix and Omega, as they have reached a laboratory validation milestone for the Marijuana Breath Test. This accomplishment signifies a crucial step towards gaining regulatory approval for the device, which has the potential to revolutionize the way marijuana intoxication is detected in various settings.
Impact on Individuals
For individuals undergoing drug testing for employment, sports, or legal reasons, the Marijuana Breath Test could bring about more accurate and efficient results. Traditional methods, such as urine tests, can detect marijuana use for days or even weeks after consumption, making it difficult to determine if someone is currently impaired. The Marijuana Breath Test, on the other hand, measures the presence of THC, the psychoactive compound in cannabis, in a person’s breath, providing a more reliable indication of recent use.
Impact on Society
Beyond the individual level, the Marijuana Breath Test may have far-reaching implications for society as a whole. In workplaces, it could help ensure a safer and more productive environment by identifying impaired employees, ultimately reducing accidents and improving overall safety. In law enforcement, it could be used to determine if a driver is under the influence of marijuana at the roadside, leading to more effective enforcement and increased public safety.
Collaboration with Omega Laboratories
The partnership between Cannabix and Omega Laboratories is a strategic move that leverages the strengths of both companies. Omega, a leading provider of drug testing services, brings extensive expertise in laboratory testing and validation, while Cannabix contributes its innovative Marijuana Breath Test technology. Together, they aim to bring this groundbreaking device to market and change the way marijuana intoxication is detected and addressed.
- Cannabix Technologies and Omega Laboratories to begin joint marketing of Marijuana Breath Test at NDASA conference
- Laboratory validation milestone achieved for Marijuana Breath Test
- Device measures THC in breath to determine recent marijuana use
- Potential to revolutionize drug testing in various settings
- Strategic partnership between Cannabix and Omega Laboratories
In conclusion, the collaboration between Cannabix Technologies and Omega Laboratories and the upcoming debut of the Marijuana Breath Test at the NDASA conference represent significant strides in the development of reliable and accurate marijuana breath testing technology. This advancement has the potential to impact individuals and society in various ways, from improving workplace safety to enhancing law enforcement efforts. As the cannabis industry continues to evolve, it is essential to adapt and innovate, and the Marijuana Breath Test is a prime example of this progress.
